共 2 条
Three-Dimensional Homodyne Light Detection (3D-HLD) for High-Throughput Submicron Particle Analysis in (Highly Concentrated) Protein Biopharmaceuticals, Viral Vectors, and LNPs
被引:0
|作者:
Brandstetter, Dominik
[1
]
Helbig, Constanze
[1
]
Osawa, Kentaro
[2
]
Minemura, Hiroyuki
[3
]
Anzai, Yumiko
[3
]
Torisu, Tetsuo
[4
]
Uchiyama, Susumu
[4
,5
]
Menzen, Tim
[1
]
Friess, Wolfgang
[6
]
Hawe, Andrea
[1
]
机构:
[1] Coriolis Pharm Res GmbH, Fraunhoferstr 18 b, D-82152 Martinsried, Germany
[2] Hitachi High Tech Corp, 1 17 1 Toranomon,Minato Ku, Tokyo 1056409, Japan
[3] Hitachi Ltd, Res & Dev Grp, 1-280 Higashi Koigakubo, Kokubunji, Tokyo 1858601, Japan
[4] Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan
[5] U Medico Inc, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan
[6] Ludwig Maximilians Univ Munchen, Dept Pharm, Pharmaceut Technol & Biopharmaceut, Butenandtstr 5-13, D-81337 Munich, Germany
关键词:
Particle size;
Three-dimensional homodyne light detection (3D-HLD);
Protein aggregation;
Protein formulation;
Biopharmaceutical characterization;
Microfluidic resistive pulse sensing (MRPS);
High throughput technology(s);
SIZE DISTRIBUTION;
FORMULATIONS;
D O I:
10.1016/j.xphs.2023.10.042
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
During biopharmaceutical development, particle monitoring and characterization are crucial. Notably, particles can be impurities considered as critical quality attribute, or active pharmaceutical ingredient (e.g., viral vectors) or drug delivery system (e.g., lipid nanoparticles) itself. Three-dimensional homodyne light detection (3D-HLD) is a novel technique that can characterize particles in the >> 0.2 m m to 2.0 m m size range. We evaluated 3D-HLD for the analysis of high concentration protein formulations (up to 200 mg/mL), where formulation refractive index and background noise became limiting factors with increasing protein concentration. Sample viscosity however did not impact 3D-HLD results, in contrast to comparative analyses with NTA and MRPS. We also applied 3D-HLD in high -throughput screenings at high protein concentration or of lipid nanoparticle and viral vector formulations, where impurities were analyzed in the presence of a small ( <0.2 m m) particulate active pharmaceutical ingredient. 3D-HLD turned out to be in good agreement with or a good complement to other state-of-the-art particle characterization techniques, including BMI, MRPS, and DLS. The main application of 3D-HLD is high -throughput particle analysis at low sample volume. Follow-up investigation of the optimized particle sizing approach and of detection settings could further improve the understanding of the method and potentially increase ease of operation. (c) 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:891 / 899
页数:9
相关论文